Multiple Sclerosis: Advances in Clinical Trial Design, Treatment and Future Perspectives.

D. et al. (Eds.) Goodkin

ISBN 10: 1852330333 / ISBN 13: 9781852330330

Published by London Springer Verlag, 1998

About this Item

Gebraucht - Gut Zustand: Gut, Mängelexemplar, XVIII, 364 pp. 28 figs., 5 colour plates. About this book: Multiple Sclerosis: Advances in Clinical Trial Design, Treatment and Future Perspectives is a review of therapeutic developments for a disease that is one of the major problems in current neurologic practice. Progress in this field has been rapid and there have been important developments in clinical trial design and a number of important trial results that have resulted in new treatment options for patients and physicians. Important ethical considerations that arise with new treatments are included, as is a perspective on the emergence of MS as a treatable disease. This book is for all neurologists, primary care physicians, and patients concerned about the treatment of MS. It will also be of value to clinical epidemiologists and biostatisticians with an interest in experimental therapies for chronic disease, to immunologists with an interest in autoimmune disease, to the pharmaceutical industry and to MS societies. Written for neurologists, neuroradiologists, researchers.

Seller Inventory # 16635

Bibliographic Details

• Title: Multiple Sclerosis: Advances in Clinical Trial Design, Treatment and Future Perspectives.
• Publisher: London Springer Verlag
• Publication Date: 1998
• Language: English
• ISBN 10: 1852330333
• ISBN 13: 9781852330330
• Binding: Softcover
• Condition: Gut

About this title

Synopsis

Multiple Sclerosis: Advances in Clinical Trial Design, Treatment and Future Perspectives is a review of therapeutic developments for a disease that is one of the major problems in current neurologic practice. Progress in this field has been rapid and there have been important developments in clinical trial design and a number of important trial results that have resulted in new treatment options for patients and physicians. Important ethical considerations that arise with new treatments are included, as is a perspective on the emergence of MS as a treatable disease. This book is for all neurologists, primary care physicians, and patients concerned about the treatment of MS. It will also be of value to clinical epidemiologists and biostatisticians with an interest in experimental therapies for chronic disease, to immunologists with an interest in autoimmune disease, to the pharmaceutical industry and to MS societies.